Advertisement
Organisation › Details
Patient Square Capital L.P.
Patient Square Capital (www.patientsquarecapital.com) is a dedicated health care investment firm that partners with best-in-class management teams whose products, services and technologies improve health. Patient Square utilizes deep industry expertise, a broad network of relationships and a true partnership approach to make investments in companies grow and thrive. Patient Square invests in businesses that strive to improve patient lives, strengthen communities, and create a healthier world. Patient Square’s team of industry-leading executives is differentiated by the depth of focus in health care, the breadth of health care investing experience, and the network it can activate to drive differentiated outcomes. *
Start | 2020-08-17 established | |
Group | Patient Square Capital (Group) | |
Industry | investment management | |
Industry 2 | healthcare | |
Person | Momtazee, Jim (Patient Square Capital 202008– Managing Partner + Co-Founder before 21 years at KKR) | |
Person 2 | Furmanski, Laura (Patient Square Capital 202210 Partner + Head of Patient Square Insights formerly Qiagen 2014–201711) | |
Region | Menlo Park, CA | |
Country | United States (USA) | |
Street | 724 Oak Grove Avenue Suite 130 | |
City | 94025 Menlo Park, CA | |
Tel | +1-650-384-6558 | |
Address record changed: 2021-06-28 | ||
Basic data | Employees | n. a. |
Currency | USD | |
Annual sales | 8,000,000,000 (assets under management (2023) 2023-12-31) | |
* Document for »About Section«: Patient Square Capital L.P.. (2/1/23). "Press Release: Patient Square Capital Announces Record $3.9 Billion Inaugural Fund". Menlo Park, CA. | ||
Record changed: 2024-04-18 |
Advertisement
More documents for Patient Square Capital (Group)
- [1] Nuclera Ltd.. (10/16/24). "Press Release: Nuclera Closes $75 Million USD Financing > Series C round led by Elevage Medical Technologies". Cambridge & Boston, MA....
- [2] NanoString Technologies, Inc.. (3/10/24). "Press Release: Patient Square Capital, a Leading Health Care-Focused Investment Firm, Agrees to Acquire NanoString Technologies". Seattle, WA....
- [3] Apollo Therapeutics. (1/2/24). "Press Release: Apollo Therapeutics Announces Second Close of Series C Financing Bringing Total Raised in Round to $260 Million". Cambridge & Boston, MA....
- [4] Apollo Therapeutics. (9/6/23). "Press Release: Apollo Therapeutics Closes $226.5 Million Series C Financing Led by Patient Square Capital". Cambridge & Boston, MA....
- [5] Upstream Bio (US). (6/20/23). "Press Release: Upstream Bio Announces $200M Series B Financing to Advance UPB-101 for Allergic and Inflammatory Diseases". Allschwil....
- [6] Patient Square Capital L.P.. (2/1/23). "Press Release: Patient Square Capital Announces Record $3.9 Billion Inaugural Fund". Menlo Park, CA....
- [7] Resolve Biosciences GmbH. (10/24/22). "Press Release: Resolve Biosciences Secures $71 Million Series B Financing to Accelerate Commercial Expansion to Meet Global Demand for Molecular Cartography Workflow". Monheim....
- [8] Kriya Therapeutics, Inc.. (5/16/22). "Press Release: Kriya Announces $270 Million Series C Financing to Advance Fully Integrated Gene Therapy Engine". Redwood City, CA & Research Triangle Park, NC....
- [9] Kriya Therapeutics, Inc.. (7/14/21). "Press Release: Kriya Therapeutics Completes $100 Million Series B Financing to Advance Its Fully Integrated Platform for Designing, Developing and Manufacturing Transformative Gene Therapies". Redwood City, CA & Rese...
- [10] Apollo Therapeutics. (6/17/21). "Press Release: Apollo Therapeutics Completes $145 Million Financing Led by Patient Square Capital to Expand and Advance Portfolio-Based Drug Development". Cambridge....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top